Real-World Outcome for Newly Diagnosed Patients with Functional High-Risk Myeloma - a Myeloma and Related Diseases Registry Analysis

被引：0

作者：

Spencer, Andrew ^{[1
]}

Mollee, Peter ^{[2
]}

Blacklock, Hilary Anne ^{[3
]}

Harrison, Simon ^{[4
,5
]}

Quach, Hang ^{[6
]}

Ho, P. Joy ^{[7
]}

Spearing, Ruth

Hocking, Jay ^{[8
]}

Augustson, Bradley ^{[9
]}

Prince, H. Miles ^{[10
]}

Moore, Elizabeth M. ^{[11
]}

McQuilten, Zoe

Wood, Erica M. ^{[11
]}

Wellard, Cameron

机构：

[1] Monash Univ, Alfred Hlth, Dept Clin Haematol, Melbourne, Vic, Australia

[2] Princess Alexandra Hosp, Dept Haematol, Brisbane, Qld, Australia

[3] Middlemore Hosp, Auckland, New Zealand

[4] Peter MacCallum Canc Ctr, Clin Haematol, Melbourne, Vic, Australia

[5] Royal Melbourne Hosp, Melbourne, Vic, Australia

[6] St Vincents Hosp, Dept Haematol, Melbourne, Vic, Australia

[7] Royal Prince Alfred Hosp, Inst Haematol, Sydney, NSW, Australia

[8] Box Hill Hosp, Dept Haematol, Melbourne, Vic, Australia

[9] Sir Charles Gairdner Hosp, Dept Haematol, Nedlands, WA, Australia

[10] Epworth Freemasons Hosp, Melbourne, Vic, Australia

[11] Monash Univ, Transfus Res Unit, Melbourne, Vic, Australia

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-129431

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

269

引用

页数：4

共 50 条

[31] A Real-World International Staging System (RW-ISS) for patients with newly diagnosed multiple myeloma
Christian Brieghel
Tobias Schmidt Slørdahl
Morten Nørgaard Andersen
Agoston Gyula Szabo
Carsten Utoft Niemann
Sigrún Thorsteinsdóttir
Blood Cancer Journal, 15 (1)
[32] Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)
Bergin, Krystal
Wellard, Cameron
Augustson, Bradley
Cooke, Rachel
Blacklock, Hilary
Harrison, Simon J.
Ho, Joy
King, Tracy
Quach, Hang
Mollee, Peter
Walker, Patricia
Moore, Elizabeth
McQuilten, Zoe
Wood, Erica
Spencer, Andrew
BONE MARROW TRANSPLANTATION, 2021, 56 (10) : 2533 - 2543
[33] Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)
Krystal Bergin
Cameron Wellard
Bradley Augustson
Rachel Cooke
Hilary Blacklock
Simon J. Harrison
Joy Ho
Tracy King
Hang Quach
Peter Mollee
Patricia Walker
Elizabeth Moore
Zoe McQuilten
Erica Wood
Andrew Spencer
Bone Marrow Transplantation, 2021, 56 : 2533 - 2543
[34] VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)
Kastritis, Efstathios
Beksac, Meral
Badelita, Sorina Nicoleta
Katodritou, Eirini
Bila, Jelena
Spanoudakis, Emmanouil
Seval, Guldane Cengiz
Cvetkovic, Zorica
Markovic, Olivera
Toprak, Selami Kocak
Dalampira, Dimitra
Coriu, Daniel
Bezirgiannidou, Zoi
Pirsic, Mario
Valkovic, Toni
Ursuleac, Iulia
Sretenovic, Aleksandra
Sevastoudi, Angeliki
Batinic, Josip
Barbu, Sinziana
Roussou, Maria
Gavriatopoulou, Maria
Terpos, Evangelos
Dimopoulos, Meletios A.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (02): : E71 - E81
[35] Is more better in myeloma? Treatment intensity and outcome in newly diagnosed myeloma patients
Fillitz M.
Seebacher A.
Panny M.
memo - Magazine of European Medical Oncology, 2015, 8 (1) : 22 - 25
[36] PROGNOSTIC IMPLICATIONS OF MULTIPLE CYTOGENETIC HIGH-RISK ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
Binder, M.
Rajkumar, S. V.
Ketterling, R. P.
Dispenzieri, A.
Lacy, M. Q.
Gertz, M. A.
Buadi, F. K.
Hayman, S. R.
Hwa, Y. L.
Zeldenrust, S. R.
Lust, J. A.
Russell, S. J.
Leung, N.
Kapoor, P.
Go, R. S.
Gonsalves, W. I.
Kyle, R. A.
Kumar, S. K.
HAEMATOLOGICA, 2017, 102 : 107 - 107
[37] Prognostic Implications of Multiple Cytogenetic High-Risk Abnormalities in Patients with Newly Diagnosed Multiple Myeloma
Binder, Moritz
Rajkumar, S. Vincent
Ketterling, Rhett P.
Dispenzieri, Angela
Lacy, Martha Q.
Gertz, Morie A.
Buadi, Francis K.
Hayman, Suzanne R.
Hwa, Yi L.
Zeldenrust, Steven R.
Lust, John A.
Russell, Stephen J.
Leung, Nelson
Kapoor, Prashant
Go, Ronald S.
Gonsalves, Wilson I.
Kyle, Robert A.
Kumar, Shaji
BLOOD, 2016, 128 (22)
[38] A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Brian A. Walker
Konstantinos Mavrommatis
Christopher P. Wardell
T. Cody Ashby
Michael Bauer
Faith Davies
Adam Rosenthal
Hongwei Wang
Pingping Qu
Antje Hoering
Mehmet Samur
Fadi Towfic
Maria Ortiz
Erin Flynt
Zhinuan Yu
Zhihong Yang
Dan Rozelle
John Obenauer
Matthew Trotter
Daniel Auclair
Jonathan Keats
Niccolo Bolli
Mariateresa Fulciniti
Raphael Szalat
Phillipe Moreau
Brian Durie
A. Keith Stewart
Hartmut Goldschmidt
Marc S. Raab
Hermann Einsele
Pieter Sonneveld
Jesus San Miguel
Sagar Lonial
Graham H. Jackson
Kenneth C. Anderson
Herve Avet-Loiseau
Nikhil Munshi
Anjan Thakurta
Gareth Morgan
Leukemia, 2019, 33 : 159 - 170
[39] A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Walker, Brian A.
Mavrommatis, Konstantinos
Wardell, Christopher P.
Ashby, T. Cody
Bauer, Michael
Davies, Faith
Rosenthal, Adam
Wang, Hongwei
Qu, Pingping
Hoering, Antje
Samur, Mehmet
Towfic, Fadi
Ortiz, Maria
Flynt, Erin
Yu, Zhinuan
Yang, Zhihong
Rozelle, Dan
Obenauer, John
Trotter, Matthew
Auclair, Daniel
Keats, Jonathan
Bolli, Niccolo
Fulciniti, Mariateresa
Szalat, Raphael
Moreau, Phillipe
Durie, Brian
Stewart, A. Keith
Goldschmidt, Hartmut
Raab, Marc S.
Einsele, Hermann
Sonneveld, Pieter
San Miguel, Jesus
Lonial, Sagar
Jackson, Graham H.
Anderson, Kenneth C.
Avet-Loiseau, Herve
Munshi, Nikhil
Thakurta, Anjan
Morgan, Gareth
LEUKEMIA, 2019, 33 (01) : 159 - 170
[40] Caution With Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma
Mohyuddin, Ghulam Rehman
Abdallah, Al-Ola
McClune, Brian
JAMA ONCOLOGY, 2021, 7 (04) : 635 - 635

← 1 2 3 4 5 →